Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ChromaDex Corporation < Previous 1 2 3 Next > Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD) June 24, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC) June 13, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT) June 07, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024 June 04, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 May 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award May 22, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports First Quarter 2024 Financial Results May 08, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® April 25, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement April 30, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 April 24, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market April 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program March 26, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results March 06, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024 February 21, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024 February 05, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference January 26, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen® December 20, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD) November 30, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients November 15, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023 November 09, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Third Quarter 2023 Financial Results November 08, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg Featuring Niagen® (Patented Nicotinamide Riboside), One of the Most Efficient Nicotinamide Adenine Dinucleotide (NAD+) Boosters Available, to Consumers Nationwide November 01, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 October 31, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex and Zesty Paws® Crack the Code on Cellular Health for Dogs With ‘Healthy Aging’ Line October 26, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC Preclinical Study Builds on Growing Body of Evidence Showcasing Exogenous Nicotinamide Mononucleotide (NMN) Must be Converted to Nicotinamide Riboside (NR), Making NR a More Efficient Nicotinamide Adenine Dinucleotide (NAD+) Precursor to NMN August 24, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients October 02, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Second Quarter 2023 Financial Results August 09, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Launches Tru Niagen® with iHerb, the World’s Number One Online Destination for Health and Wellness August 08, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series August 07, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023 August 02, 2023 From ChromaDex Corporation Via Business Wire Tickers CDXC < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.